Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 15, 2003Journal of Neurology Neurosurgery & PsychiatryOpen Access

Treatment of IgM antibody associated polyneuropathies using rituximab

View Full Paper
Ask AI
Bookmark
Share

Authors

APAlan PestronkTufts University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Alan Pestronk (2003) studied this question.

synapsesocial.com/papers/6a781ceede5e3adfbdf76096https://doi.org/10.1136/jnnp.74.4.485
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Rituximab Chimeric Anti-CD20 Monoclonal Antibody Therapy for Relapsed Indolent Lymphoma: Half of Patients Respond to a Four-Dose Treatment Program2023 · 123 citations
  2. 2Distal lower motor neuron syndrome with high‐titer serum IgM anti‐GM 1 antibodies1994 · 66 citations
  3. 3Immunosuppressive treatment in multifocal motor neuropathy1991 · 188 citations
  4. 4Multifocal motor neuropathy1997 · 115 citations
  5. 5Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.1998 · 2,771 citations